Malignant hypercalcaemia.
Author:
- J C StevensonJSJ C Stevenson
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Role of glucocorticoids in management of malignant hypercalcaemia.BMJ, 1984
- An interleukin 1 like factor stimulates bone resorption in vitroNature, 1983
- Tumor-Derived Growth Factor Increases Bone Resorption in a Tumor Associated with Humoral Hypercalcemia of MalignancyScience, 1983
- A Parathyroid Hormone Inhibitor in Vivo: Design and Biological Evaluation of a Hormone AnalogScience, 1983
- HYPERCALCAEMIA AND METASTATIC BONE DISEASE: IS THERE A CAUSAL LINK?The Lancet, 1982
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.Journal of Clinical Investigation, 1980
- INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- PROSTAGLANDINS AND BREAST CANCERThe Lancet, 1977
- EVIDENCE THAT THE BONE RESORPTION-STIMULATING FACTOR PRODUCED BY MOUSE FIBROSARCOMA CELLS IS PROSTAGLANDIN E2Journal of Experimental Medicine, 1972
- FAILURE OF CORTICOSTEROID THERAPY TO CORRECT THE HYPERCALCÆMIA OF MALIGNANT DISEASEThe Lancet, 1970